LAUSR

Abstract Purpose Obesity is one of the rising health problems and has become a major concern with highest prevalent global epidemiology. Various evidences suggest that the action or effect of glucagon-like-peptide-1 (GLP-1), which acts as a satiety signal may be impaired in obese subjects. Dipeptidyl peptidase-4 (DPP-4) is the principal enzyme that metabolizes GLP-1 and sitagliptin, a DPP-4 inhibitor which prevents the breakdown of GLP-1. Thus the purpose of the present study was to investigate the beneficial effect of sitagliptin, a DPP-4 inhibitor on body weight gain, adiposity and biochemical anomalies in rats. Materials and methods In the present study chronic administration of sitagliptin (10, 20 and 40 mcg/kg/day p.o) for 6 weeks along with high fat diet to the obese rats which were pretreated with high fat diet feeding for 4 weeks on the various parameters of obesity were analyzed. Their effects on body weight, feed intake (kcal), weight and size of fat pads, levels of serum glucose, triglycerides, total cholesterol, high density lipoproteins (HDL) and low density lipoprotein were analyzed. Results Treatment with sitagliptin (10, 20 and 40 mcg/kg/day p.o) produced significant dose dependent decrease (p